Zobrazeno 1 - 5
of 5
pro vyhledávání: '"S. pneumoniae, Streptococcus pneumoniae"'
Publikováno v:
The Journal of Hospital Infection
Summary Background The impact of the coronavirus disease (COVID-19) pandemic on antimicrobial resistance (AMR) is a major concern. Aim To compare the number of patients and isolation rate of antimicrobial-resistant bacteria before and after the begin
Autor:
Hirofumi Chiba, Naofumi Bunya, Satoshi Takahashi, Koji Kuronuma, Eichi Narimatsu, Kazunori Oishi, Bin Chang, Yoshihiro Fujiya
Publikováno v:
Journal of Infection and Chemotherapy
A 68-year-old man experienced fever and cough and was referred to a hospital for day 4. He had a positive reverse transcription-polymerase chain reaction result for severe acute respiratory syndrome coronavirus-2. On day 12, his PaO2/FiO2 ratio worse
Autor:
Aki, Miyauchi, Wataru, Watanabe, Toshi, Akashi, Seiko, Hashiguchi, Hiroki, Yoshida, Chihiro, Sugita, Masahiko, Kurokawa
Publikováno v:
Toxicology Reports
Graphical abstract
Highlights • We made inactivated Streptococcus pneumoniae (ISP) as non-pathogenic particles. • We evaluated effects of ISP on development of pneumonia by RSV infection in mice. • ISP didn’t show histopathological effec
Highlights • We made inactivated Streptococcus pneumoniae (ISP) as non-pathogenic particles. • We evaluated effects of ISP on development of pneumonia by RSV infection in mice. • ISP didn’t show histopathological effec
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Miyauchi A; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Watanabe W; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Akashi T; Department of Microbiology and Infectious Diseases, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Hashiguchi S; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Yoshida H; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Sugita C; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan., Kurokawa M; Departments of Biochemistry and Microbiology, Graduate School of Clinical Pharmacy, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan.
Publikováno v:
Toxicology reports [Toxicol Rep] 2019 May 31; Vol. 6, pp. 514-520. Date of Electronic Publication: 2019 May 31 (Print Publication: 2019).